These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 20634489)
1. CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease. Kim H; Cho HJ; Kim SW; Liu B; Choi YJ; Lee J; Sohn YD; Lee MY; Houge MA; Yoon YS Circ Res; 2010 Sep; 107(5):602-14. PubMed ID: 20634489 [TBL] [Abstract][Full Text] [Related]
2. Cultured human bone marrow-derived CD31(+) cells are effective for cardiac and vascular repair through enhanced angiogenic, adhesion, and anti-inflammatory effects. Kim SW; Houge M; Brown M; Davis ME; Yoon YS J Am Coll Cardiol; 2014 Oct; 64(16):1681-94. PubMed ID: 25323256 [TBL] [Abstract][Full Text] [Related]
3. Human peripheral blood-derived CD31+ cells have robust angiogenic and vasculogenic properties and are effective for treating ischemic vascular disease. Kim SW; Kim H; Cho HJ; Lee JU; Levit R; Yoon YS J Am Coll Cardiol; 2010 Aug; 56(7):593-607. PubMed ID: 20688215 [TBL] [Abstract][Full Text] [Related]
4. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia. Finney MR; Greco NJ; Haynesworth SE; Martin JM; Hedrick DP; Swan JZ; Winter DG; Kadereit S; Joseph ME; Fu P; Pompili VJ; Laughlin MJ Biol Blood Marrow Transplant; 2006 May; 12(5):585-93. PubMed ID: 16635794 [TBL] [Abstract][Full Text] [Related]
5. Angiogenic Mechanisms of Human CD34 Mathiyalagan P; Liang Y; Kim D; Misener S; Thorne T; Kamide CE; Klyachko E; Losordo DW; Hajjar RJ; Sahoo S Circ Res; 2017 Apr; 120(9):1466-1476. PubMed ID: 28298297 [TBL] [Abstract][Full Text] [Related]
6. Far infra-red therapy promotes ischemia-induced angiogenesis in diabetic mice and restores high glucose-suppressed endothelial progenitor cell functions. Huang PH; Chen JW; Lin CP; Chen YH; Wang CH; Leu HB; Lin SJ Cardiovasc Diabetol; 2012 Aug; 11():99. PubMed ID: 22894755 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic angiogenesis by autologous adipose-derived regenerative cells: comparison with bone marrow mononuclear cells. Hao C; Shintani S; Shimizu Y; Kondo K; Ishii M; Wu H; Murohara T Am J Physiol Heart Circ Physiol; 2014 Sep; 307(6):H869-79. PubMed ID: 25063790 [TBL] [Abstract][Full Text] [Related]
8. Robust angiogenic properties of cultured human peripheral blood-derived CD31⁺ cells. Kim MH; Jin E; Zhang HZ; Kim SW Int J Cardiol; 2013 Jul; 166(3):709-15. PubMed ID: 22188988 [TBL] [Abstract][Full Text] [Related]
9. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells. Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425 [TBL] [Abstract][Full Text] [Related]
10. Glyoxalase-1 overexpression in bone marrow cells reverses defective neovascularization in STZ-induced diabetic mice. Vulesevic B; McNeill B; Geoffrion M; Kuraitis D; McBane JE; Lochhead M; Vanderhyden BC; Korbutt GS; Milne RW; Suuronen EJ Cardiovasc Res; 2014 Feb; 101(2):306-16. PubMed ID: 24259499 [TBL] [Abstract][Full Text] [Related]
12. Erythropoietin priming improves the vasculogenic potential of G-CSF mobilized human peripheral blood mononuclear cells. Kang J; Yun JY; Hur J; Kang JA; Choi JI; Ko SB; Lee J; Kim JY; Hwang IC; Park YB; Kim HS Cardiovasc Res; 2014 Oct; 104(1):171-82. PubMed ID: 25082847 [TBL] [Abstract][Full Text] [Related]
14. Bone-marrow-derived very small embryonic-like stem cells in patients with critical leg ischaemia: evidence of vasculogenic potential. Guerin CL; Loyer X; Vilar J; Cras A; Mirault T; Gaussem P; Silvestre JS; Smadja DM Thromb Haemost; 2015 May; 113(5):1084-94. PubMed ID: 25608764 [TBL] [Abstract][Full Text] [Related]
15. TLR2-deficiency of cKit+ bone marrow cells is associated with augmented potency to stimulate angiogenic processes. Wagner NM; Bierhansl L; Butschkau A; Noeldge-Schomburg G; Roesner JP; Vollmar B Int J Clin Exp Pathol; 2013; 6(12):2813-23. PubMed ID: 24294367 [TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived cells do not engraft into skeletal muscle microvasculature but promote angiogenesis after acute injury. Ieronimakis N; Hays A; Reyes M Exp Hematol; 2012 Mar; 40(3):238-249.e3. PubMed ID: 22155292 [TBL] [Abstract][Full Text] [Related]
17. CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases. Lee JH; Lee SH; Yoo SY; Asahara T; Kwon SM Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1622-34. PubMed ID: 23640491 [TBL] [Abstract][Full Text] [Related]
18. Human marrow-isolated adult multilineage-inducible (MIAMI) cells protect against peripheral vascular ischemia in a mouse model. Rahnemai-Azar A; D'Ippolito G; Gomez LA; Reiner T; Vazquez-Padron RI; Perez-Stable C; Roos BA; Pham SM; Schiller PC Cytotherapy; 2011 Feb; 13(2):179-92. PubMed ID: 20839998 [TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine differentially regulates the populations of bone marrow and circulating endothelial progenitor cells in mice with limb ischemia. Cui Y; Liu L; Xiao Y; Li X; Zhang J; Xie X; Tian J; Sen CK; He X; Hao H; Liu Z Eur J Pharmacol; 2020 Aug; 881():173233. PubMed ID: 32492379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]